?Column Commentary?

After analyzing the commodification harvest of emotional capital on the human emotional world, we have reached the forefront of the alchemy of generalized capital and the most touching realm of the essence of existence - the ontology of life. When land, labor, emotions, and spirit are all incorporated into the track of capital growth, the ultimate goal of capital logic finally emerges: life itself. From gene sequences to cellular functions, from metabolic data to health status, from aging intervention to biological potential development, human biological existence is being systematically redefined as measurable, optimizable, modifiable, and tradable 'biological capital'. In this issue, we focus on the core form of this generalized capital matrix, examining the revolution that transforms life from a natural gift to the "ultimate project" of capital proliferation. We see how it reconstructs the rules of birth, aging, sickness, and death through monopolizing life information and regulatory power, becoming the core force that directly targets the survival and quality needs of human life.

Introduction: Life, the Last 'Capital Frontier' - The Rise of Biological Capital in the Generalized Capital System

The discovery of the double helix structure of DNA in the mid-20th century revealed a corner of the genetic code of life and quietly opened the door to the imagination that "life can be used as an engineering object". Today, more than half a century later, with the sharp decline in the cost of gene sequencing, the popularization of gene editing technologies such as CRISPR, the rise of synthetic biology, breakthroughs in brain computer interfaces, and the deep application of artificial intelligence in biological big data, we are standing at a historic threshold: life is rapidly transforming from a "mystery" that needs to be understood to a "new continent" that needs to be developed, optimized, and capitalized.

Biological capital is the ultimate evolution of the broad form of capital in the era of life sciences, and it is also a systematic integration and sublimation of the original concept of "health capital". The essence of alchemy lies in transforming the biological information and regulatory power of life processes (from molecules to organisms, from health maintenance to life extension) into technological and data assets that can be protected by private intellectual property, standardized operations, and generate sustained economic returns. This is no longer just a shallow investment in labor (human capital) or health consumption, but a direct development and transformation of the "source code of life" and "body hardware" themselves, perfectly undertaking the core logic of the infiltration of generalized capital into the realm of human essence.

Pharmaceutical giants monopolize the right to treat specific diseases by locking pathogenic gene targets through patents; Technology companies continuously collect biometric data through wearable devices to build "digital twins" for predicting health risks; Venture capital is pouring into "Longevity Technology" in an attempt to define aging as a treatable "disease"; The rise of high-end health management, anti-aging technology, functional food and other industries has transformed daily health needs into sustained capital growth carriers. Biological capital promises a "healthy, long-lived, and enhanced" future, but its underlying logic is to incorporate the entire life cycle into the precise calculation and ownership framework of generalized capital.

This article uses the "Triple Five Dimensional" framework to dissect the capital logic behind this "life project": how does the essence of the relationship between biological capital manifest as exclusive possession of "life information and regulatory power"? How does its athletic characteristics follow the closed loop of "read edit optimize subscribe"? Why is the essence of its benefits "life data rent" and "biological enhancement premium"? Understanding biological capital is the core key to understanding the economic drivers behind the contemporary biological industry revolution, health consumption upgrading, and bioethical controversies. It is also the key to grasping the logic of the infiltration of broad capital into the essence of life.

1? The biological core of the triple regulatory nature of capital

1.1 Essence of Relationship: Monopoly of "Life Information and Regulation Power" and Capitalization of Life Politics

The core power of biological capital lies not in the possession of traditional means of production such as land and machinery, but in monopolizing the most essential "source code" (genetic information), "operational data" (biometric data), and "regulatory technology" (gene editing, drug development, health intervention methods) of life, and transforming them into exclusive proliferation resources in the broad capital system. Generalized capital achieves domination over the essence of life through three layers of logic:

• Bundle sales of "Life Problems - Biological Solutions"Capital first redefines the biological state of humans, systematically pathologizing natural aging processes, individual differences in health indicators, and occasional physiological discomforts into "biological defects" that require technological intervention, "performance shortcomings" that urgently need optimization, or "life risks" that must be prevented and controlled. Subsequently, it provides standardized "biological solutions": genetic testing and editing, targeted drugs, high-end health management, anti-aging therapies, forming a self fulfilling prophecy - you purchase services because you believe that your "biological performance is insufficient", and consumer behavior itself reinforces the recognition that "life requires capital intervention". Capital becomes a mandatory intermediary between individuals and their own lives, profoundly affecting the logic of life proliferation of broad capital.
• Privatization and monopoly of biological knowledge and technologyTraditionally, human understanding of life and maintenance of health have relied on public healthcare systems, traditional medical wisdom, and individual life experiences.And biological capital transforms life science knowledge into private property rights by promoting the patenting of core technologies such as gene sequencing, biopharmaceuticals, and gene editing - pharmaceutical companies monopolize the treatment rights of pathogenic gene targets, technology giants monopolize the interpretation rights of biological data, and biotechnology companies control the application rights of gene editing, forming a private monopoly on the core resources of life and becoming an important means of broad capital life colonization.
• The Capitalization Extension of Life PoliticsBiological capital fully integrates Foucault's concept of "life politics" (the regulation of the life processes of populations) into the track of capital proliferation. From the collection of national health data to the promotion of personalized health plans, from the industrialization of vaccination to the marketization of longevity technology, capital achieves deep extraction of the value of life through full monitoring, intervention, and optimization of the life process. Health is no longer a basic human right, but a "biological value-added service" that requires payment to purchase; Life expectancy is no longer a natural process, but a "life investment project" that requires capital investment, becoming the core driving force for the proliferation of generalized capital.

1.2 Sports Characteristics: The "Life Information Regulation" Loop of R-E-O-S'

The value appreciation of biological capital follows a complete closed loop from reading life information to continuously providing biological regulatory services, which can be accurately summarized as R-E-O-S'. This is also the core movement logic that distinguishes it from other forms of capital, perfectly adapting to the long-term growth demands of general capital:

• R (Reading, Life Information Reading)The starting point of the cycle is also the core data accumulation link of generalized capital. Through technologies such as gene sequencing, wearable device monitoring, medical imaging scanning, and metabolomics analysis, capital comprehensively reads an individual's biological information - gene sequences, physiological indicators, metabolic data, and health status - to construct a complete "biological data archive", laying a data foundation for the proliferation of life in a broad sense of capital.
• E (Editing/Engineering, Biological Editing and Engineering)Based on the read life information, capital utilizes technologies such as gene editing, cell therapy, and synthetic biology to precisely intervene or engineer the life process - repairing pathogenic genes, modifying cell functions, developing targeted drugs, designing biological organs, and transforming life science technology into practical "bioengineering products", becoming the core carrier of the broad capital biotechnology industrialization.
• O (Optimizing, biological state optimization)In response to the needs of health maintenance, aging intervention, and potential development, capital provides standardized biological state optimization services - high-end health management, anti-aging therapy, functional foods, and physical fitness enhancement training, pushing individual biological states from "healthy" to "better", realizing the appreciation of life value, and becoming the core link of generalized capital biological proliferation.
• S' (Subscription&Capitalization)The ultimate form of closed loop is also the key to achieving sustained growth of biological capital. By adopting a subscription based model (such as long-term health management services, anti-aging treatment packages, and genetic data interpretation memberships), capital can lock in individuals' long-term biological service needs and achieve stable cash flow; At the same time, transforming biological data, patented technology, and bioengineering products into tradable capital assets (such as biotech company listings, patent authorizations, and data collaborations) to achieve the large-scale proliferation of broad capital.

The core of this closed loop lies in the continuity of the life process, which determines that the proliferation of biological capital has a "lifelong binding" characteristic - from genetic testing after birth to anti-aging treatment in old age, an individual's entire life cycle may become a breeding ground for biological capital, allowing the life cycle of generalized capital to continue to operate.

1.3 Essence of Benefits: Life Data Rent, Biological Patent Premium, and Health Subscription Fee

The source of benefits for biological capital comes from the systematic development and harvesting of the core resources of life, which is the most exclusive and high value-added form of benefits in the broad capital system. The core is reflected in three forms, which are in line with the high-end proliferation logic of broad capital:

• Life Data RentBiological data is the most fundamental means of production for biological capital. By continuously collecting individual genetic data, physiological indicators, and health status data, capital transforms them into digital assets that can be analyzed, traded, and monetized - selling disease-related data to pharmaceutical companies, providing user profiles to health management agencies, authorizing data usage rights to research institutions, and collecting continuous "life data rent", becoming the basic income of general capital in the field of biology.
• Premium for biological patentsThe patent monopoly on core biotechnology is the core means for biological capital to obtain excess profits. From pathogenic gene target patents to targeted drug patents, from gene editing technology patents to biological organ research and development patents, capital monopolizes the right to use core technologies and charges high patent licensing fees and product premiums to medical terminals and patients, forming a profit model of "one-time research and development, lifelong benefit", which has become the core income of broad capital in the field of biology.
• Health subscription and enhanced service feesIn the field of health management and biological enhancement, capital charges individuals a continuous "health subscription fee" and "biological enhancement service fee" by providing subscription based health management, phased anti-aging treatments, and personalized biological enhancement services. From ordinary health monitoring members to high-end longevity technology packages, from basic physical fitness enhancement to cutting-edge cognitive improvement, biological capital provides tiered services based on individual payment ability, captures high premiums, and becomes the highest form of profit acquisition, as well as the excess returns of general capital in the field of biology.

2? The biological dimension of the five dimensional attributes of interests

Based on the "Five Dimensional Attribute" analysis framework, it is possible to comprehensively deconstruct the ways in which biological capital realizes its interests, clearly presenting its all-round domination over the human life world, and perfectly fitting the diverse proliferation characteristics of generalized capital.

2.1 Subjectivity: From "People with Life" to Broad Capital "Biological Asset Managers"

Under the logic of biological capital, the subjectivity of individuals undergoes fundamental alienation, from being "complete individuals with natural life" to becoming "biological asset managers" of generalized capital, with three core manifestations:

• Self is a biological enterpriseIndividuals become lifelong CEOs of their own "biological capital", requiring monitoring of their life status, management of biological data, optimization of their health status, and development of their life potential. All activities related to life revolve around "biological capital appreciation", and life itself becomes a tool for realizing capital value, deeply integrated into the proliferation system of generalized capital.
• The solidification of 'biological consumers'Faced with their own health problems, aging anxiety, and biological potential development needs, individuals' first reaction is no longer natural conditioning or seeking public medical help, but to "purchase what kind of biological products or services to solve", completely transferring the control of life to capital and becoming a passive carrier of generalized capital biological proliferation.
• The universalization of 'biological data producers'Through wearable devices, medical testing, health apps, etc., individuals continue to produce biological data for capital, but often cannot control the right to use and profit from this data, becoming the "tenant farmers" of biological capital and providing core materials for the proliferation of biological data in general capital.

2.2 Objectivity: from "life itself" to generalized capital "biological data", "patented technology" and "health solutions"

The core object of operation and trading of biological capital is not human natural life itself, but highly technological, commercialized, and data-driven biological resources and services. Its core can be divided into three categories, adapted to the abstract and proliferative characteristics of general capital:

• Biological Data AssetsIncluding gene sequence data, physiological index data, metabolic data, health status data, etc., it is the most basic trading object of biological capital, providing core support for biotechnology research and development, health risk prediction, and drug development, and becoming the basic trading object of general capital in the field of biology.
• Biological Patent TechnologyFrom gene editing technology, targeted drug formulations to biological organ research and development achievements, patents of various core biological technologies have become the most valuable trading objects of biological capital. Through patent authorization and technology transfer, value realization is achieved, becoming the core trading objects of general capital in the field of biology.
• Biological Health ProgramStandardized health management packages, personalized anti-aging treatments, and precise disease treatment plans, these comprehensive solutions that integrate technology, services, and data, have become the most competitive trading objects for biological capital in the market. Through direct sales to individuals, they achieve proliferation and become high-value trading objects for general capital in the field of biology.

2.3 Process oriented: Reading biological information, developing core technologies, providing customized services

The realization of the benefits of biological capital is a complex process that integrates scientific research and development, technological transformation, and market services. Its core logic is "data-driven technology breakthrough service monetization", which perfectly adapts to the efficient proliferation characteristics of generalized capital:

1. Biological data collection and analysisThrough various detection devices, wearable terminals, and medical systems, large-scale collection of individual biological data is carried out, and AI algorithms are used for in-depth analysis to explore disease risks, health shortcomings, and biological potential, in order to lock in target demands for the biological proliferation of generalized capital;
2. Core technology research and development and patent layoutBased on data insights, invest huge amounts of funds in biotechnology research and development (such as gene editing, targeted drugs, anti-aging technology), and build technological barriers through patent applications to ensure the technological exclusivity of broad capital;
3. Customized development of products and servicesTransforming core technologies into standardized or personalized biological products and services (such as genetic testing packages, targeted drugs, and health management services) to meet the life needs of different individuals and promote the large-scale proliferation of broad capital;
4. Subscription based services and secondary monetization of dataThrough long-term subscriptions, membership services, and other models, individuals' sustained needs are locked in. At the same time, desensitized biological data is authorized to pharmaceutical companies and research institutions to achieve secondary data proliferation and complete the continuous return loop of generalized capital.

2.4 Timeliness: The logic of colonization throughout life and the long-term proliferation of generalized capital

Biological capital has shaped the proliferation logic of "lifelong binding" by comprehensively covering the dimension of life time. Its core is reflected in three points, which profoundly affect the time proliferation logic of general capital:

• Continuous infiltration throughout lifeFrom embryonic genetic testing to child health management, from youth potential development to anti-aging treatments for middle-aged and elderly individuals, the services of biological capital cover every stage of an individual's life, transforming the entire life process into a breeding ground and becoming the core carrier of long-term proliferation of broad capital;
• Early monetization of future healthBiological capital predicts disease risks and aging trends, and converts future health needs into current consumption behavior in advance - such as purchasing cognitive enhancement services in advance to prevent Alzheimer's disease, subscribing to anti-aging treatments in advance to delay aging, and discounting future returns of broad capital;
• Continuous drive of technological iterationThe rapid iteration of biotechnology (such as gene editing technology upgrades and anti-aging drug updates) requires individuals to continuously purchase new generation products and services to maintain "biological capital appreciation", forming a cycle of "technology iteration consumption upgrade" and promoting the circulation and proliferation of broad capital.

2.5 Spatiality: Global Coverage from Physical Medical Scenarios to Generalized Capital's "Biodigital Space"

The spatial expansion of biological capital has achieved full coverage from physical medical facilities to digital spaces, from professional scenarios to daily scenarios, allowing capital to colonize life far and wide, perfectly adapting to the global proliferation characteristics of generalized capital

• Commercialization of Physical Biological Industry SpaceTransforming specialized spaces such as hospitals, biological laboratories, health management centers, and anti-aging clinics into high fee biological service venues, charging high fees through professional equipment, technical teams, and customized services, and becoming a biological proliferation carrier for general capital in physical spaces;
• Construction of Biological Digital SpaceBy leveraging health apps, remote medical platforms, biological data cloud platforms, and virtual reality medical scenarios, we aim to build ubiquitous virtual "biological service spaces" - such as online health monitoring, remote diagnosis and treatment, and digital twin health simulations - allowing individuals to consume and provide biological data anytime and anywhere, achieving seamless penetration of capital into the living space and becoming a biological proliferation carrier for generalized capital in the virtual space;
• The 'biological colonization' of daily spaceCapital constantly advocates for "health monitoring at home", "wearing biosensing devices during commuting", and "daily consumption of functional foods", integrating biological data collection, health management, and biological enhancement into every aspect of daily life, making all human daily spaces a breeding ground for biological capital and a biological breeding carrier for broad capital in daily spaces.

3? Digital Empowerment: The Capital Revolution of Biodataization and Precision Medicine

Digital technology is the core accelerator for the comprehensive expansion and precise proliferation of biological capital. It enables capital to capture life more accurately, technology transformation more efficiently, and service coverage more widely, promoting the biological industry to enter a new stage of digitization and precision. It has become the ultimate means of empowering the proliferation of biological capital and an important manifestation of the digital transformation of general capital

• Precision research and development driven by biological dataization and AIDigital technology promotes the large-scale collection and deep analysis of biological data. AI algorithms can quickly explore the correlation between genes and diseases, physiological indicators and health risks, accelerate the development process of targeted drugs, gene therapies, and anti-aging technologies, reduce research and development costs, improve success rates, and achieve efficient proliferation of generalized capital;
• Digital Twin and Personalized Health ManagementBy integrating multidimensional biological data, constructing an individual's "biological digital twin", simulating changes in health status, disease development trends, and treatment effect predictions, providing individuals with precise and personalized health management solutions, enhancing the added value of biological services, while locking in long-term consumer demand, and achieving precise proliferation of generalized capital;
• Remote biological services and global coverageDigital technology breaks geographical limitations, allowing high-end biological services (such as expert diagnosis and treatment, precision health management) to break through geographical barriers, cover a wider population, and expand the biological growth space of broad capital through remote medical care, online health consultation, and real-time transmission of wearable device data.

4? Systemic Paradox: The Prosperity of the Biological Industry and the Alienation of the Essence of Life

The rise of biological capital has given birth to a large-scale biological industry, promoting the rapid development of medical technology, health management, and anti-aging technology. However, this capital movement, with the slogan of "improving the quality of life and extending the length of life", ultimately went to its opposite, creating a profound systemic paradox that plunged the human life world into complete alienation and exposed the inherent contradictions of the generalized capital system

• The life dilemma of 'more intervention, more anxiety'Individuals continue to consume biological products and services in pursuit of health and anti-aging, such as genetic testing, targeted drugs, and anti-aging treatments. However, biological capital constantly creates new concepts of "biological defects" (such as "genetic susceptibility risks" and "potential health hazards"), leading individuals into a vicious cycle of "testing anxiety consumption retesting". The more prosperous the biotechnology industry is, the more severe human life anxiety becomes, which is the core paradox of generalized capital in the field of biology.
• The ultimate irony of 'commodified life'The core selling point of biological capital is "respecting life and enhancing its value", but it breaks down life itself into tradable biological data, patented technology, and health solutions, simplifying the value of life into economic value and turning natural life processes into tools for capital proliferation. The value paradox of generalized capital in the field of biology is that individuals attempt to obtain more valuable life through capital intervention, but in the process lose the true meaning of life.
• The exacerbation of life inequality and the widening of the biological divideHigh end biotechnology, such as gene editing, advanced anti-aging, and precision medicine, often comes at a high price and can only be enjoyed by a few wealthy individuals, creating a "biological privilege" - the wealthy extend their lifespan and optimize their health through capital investment, while ordinary people are deprived of equal opportunities due to insufficient payment ability, exacerbating social inequality and forming a profound "biological divide". This is the social paradox of broad capital in the field of biology.
• Breakthrough of the Bottom Line of BioethicsIn pursuit of capital proliferation, biological capital constantly challenges the ethical boundaries of life - embryo gene editing, human enhancement technology, and biological data privacy breaches. These behaviors may trigger unpredictable biological risks and social problems, but are constantly driven by the profit driven impulse of capital, threatening the overall survival and safety of humanity. This is the ethical paradox of generalized capital in the field of biology.

5? The positioning of biological capital in the generalized capital game

In the generalized capital matrix, biological capital presents a complex relationship of "mutual empowerment and mutual constraint" with other forms of capital, and its positioning has a distinct duality:

• As a 'life enabler'Biological capital provides key support for the collaboration of various forms of capital: industrial capital achieves product upgrades through biomanufacturing, technological capital relies on breakthroughs in biotechnology to obtain patent benefits, commercial capital realizes value realization through the marketing of biological products, digital capital recommends through biological data integration optimization algorithms, and biological capital becomes the "core engine" in the generalized capital system to promote industrial upgrading and meet ultimate needs, promoting value co creation among various forms of capital;
• As a 'contradiction amplifier'The alienation logic of biological capital conflicts with the overall interests of generalized capital: its excessive commodification of life exacerbates social inequality, the privatization and monopoly of biological data triggers privacy crises, and the breakthrough of ethical boundaries brings potential risks. The excessive expansion of biological capital not only exacerbates the contradictions within the broad capital system, but also may trigger a crisis in bioethics, damaging the long-term sustainable development of broad capital.

Conclusion: Recovering the Sovereignty of Life - Beyond the Capitalization of Natural Life

The analysis using the "triple five dimensional" framework reveals that biological capital is a precise device for systematically capturing and commercializing the most essential human life existence. The essence of its relationship is the monopoly of "life information and control rights", and the movement logic is a continuous cycle of "reading editing optimization subscription". The core interest lies in levying "data rent" on life resources, collecting "patent premiums" and "health subscription fees". In the digital age, with the help of biotechnology and big data technology, it has achieved "precise intervention" and "full colonization" of the human life world, giving birth to the prosperity of the biotechnology industry and the alienation of the essence of life, becoming a highly dominant form in the broad capital system.

The domination of biological capital is gentle and thorough. It uses "health, longevity, and enhancement" as bait, allowing us to voluntarily put on new shackles on the path of pursuing quality of life, and experience deeper life exploitation in the commitment to improving our living conditions. This is a concentrated manifestation of the infiltration of the logic of broad capital into the essence of human life.

To surpass biocapitalism, it is not to oppose the development of biotechnology or deny the value of health management, but to be vigilant and resist the logic of fully capitalizing and commoditizing the entire life process, to regain the sovereignty of human life, and to return to the natural and authentic life experience. This requires us to do three things: first, defend the public attributes of the field of life, strengthen the construction of the public healthcare system, ensure the universality of basic health services, defend these "life commons" that cannot be monopolized by capital, and set boundaries for the biological colonization of broad capital; The second is to regulate the development boundary of biological capital, establish the bottom line of biotechnology application through legal and ethical constraints, protect the privacy of biological data, prevent capital from breaking through bioethics, and break free from the life domination of generalized capital; The third is to reshape the concept of life values, return to the value pursuit of "the essence of life", reject the "biological optimization" standard defined by capital, respect the natural life process, realize the value of life in harmonious coexistence with nature, and let biological capital return to the essence of serving humanity.

The ultimate meaning of life has never been a meticulously designed and endless game of "biological upgrading" by capital, but a clear journey through the fog of various biological marketing and commercial solutions, facing the true face of life, respecting the natural cycle of birth, aging, sickness, and death, and enjoying a true and complete life experience. Recovering the sovereignty of our life experience is a profound struggle in our era that concerns the survival of humanity, and it is also an inevitable requirement for the healthy development of the broad capital system.

?Next Episode Preview?

When biological capital focuses on the essence of human life, another form of capital turns its attention to the external nature that humans rely on for survival - ecological capital. In the next issue, we will focus on ecological capital and analyze how it transforms natural ecological resources such as air, water, land, and climate into quantifiable, tradable, and replicable economic assets. We will see how it constructs an ecological centered industrial loop in the broad capital system, becoming a key force in balancing economic development and nature conservation. Please stay tuned for "Ecological Capital Interest Theory: Natural Capitalization and Ecological Industry Revolution under the Triple Five Dimensional Framework".